Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Visible Genetics Inc.(VGIN) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Haugland who wrote (162)	3/16/1998 10:17:00 AM
From: scaram(o)uche	Respond to of 337

Some may have a different spin, but I see this as a positive.... prnewswire.com (Abbott buys MURXF for $13/share) Cheers! Rick

To: Richard Haugland who wrote (162)	3/17/1998 8:55:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 337

prnewswire.com If VGINF can now manage the regulatory aspects with professional polish, we're launched. They are choosing to start HIV kits at low margin (giving away the sequencer), and I'd bet that this agreement gives CPI a very good deal. I love this strategy, and I'm betting that we now stand a better chance to see revenues soar, mid-'99. IMO, a very, very clever move. This place (VGINF) must be frantic, just frantic as hell. Stevens et al. deserve kudos for this move. Rick